Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Industry Eyes Thai Elections For Compulsory License’s Future

This article was originally published in PharmAsia News

Executive Summary

Recent elections in Thailand raise questions about the future of the country's compulsory license policy, which the Pharmaceutical Research and Manufacturers of America says erodes Thailand's intellectual property system

You may also be interested in...



Local Thai Drug Makers Urging Compulsory Licensing “Ill-Informed” – PReMA President

PERTH, Australia - Local Thai drug makers are urging the Thai government to issue compulsory licenses for three patented cancer drugs, saying the licenses are legal and would benefit Thailand, the Bangkok Post reported

Local Thai Drug Makers Urging Compulsory Licensing “Ill-Informed” – PReMA President

PERTH, Australia - Local Thai drug makers are urging the Thai government to issue compulsory licenses for three patented cancer drugs, saying the licenses are legal and would benefit Thailand, the Bangkok Post reported

Thailand’s Ministers Of Health, Commerce And Foreign Affairs Conclude Compulsory Licensing Legal

PERTH, Australia - A plan by Thailand's new Public Health Minister Chaiya Sasomsab to review the country's policy on compulsory licensing for four cancer drugs has stalled again after three ministry officials said the policy could not be revoked, the Bangkok Post reported Feb. 20

Related Content

UsernamePublicRestriction

Register

OM003387

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel